视疲劳的诊断及药物治疗  

The diagnosis and drug treatment of asthenopia

作　　者：卢颖[1] 赵秋溪[1] 钱勇[1] 段文静[1] 赵淼焱[1] 张丽筠[1] 杩红燕[1] 

机构地区：[1]北京电力医院眼科,北京100073

出　　处：《食品与药品》2006年第03A期37-38,共2页Food and Drug

摘　　要：目的探讨临床诊断视疲劳的客观依据及润尔乐治疗后的效果。方法对临床诊断为视疲劳的143例患者进行自身对照研究,常规眼部检查,用润尔乐4次/d,2个月后复查。结果治疗前132例患者有不同程度的角膜上皮后纤维增生;用药后减轻或消失。结论凡是检查见角膜上皮后纤维增生可诊断为视疲劳;润尔乐对治疗视疲劳有效。Objective To approach the objective clinical diagnosis standards for asthenopia and to study the curative effect of Chondroitin Sulfate Eye Drops. Methods 143 cases with asthenopia were involved in the own control study and accepted routine ocular examination. Chondroitin Sulfate Eye Drops were used four times a day. After two months cases were rechecked. Results Before treatment 132 cases were diagnosed with corneal epithelium post fibrosis with different degrees, while the symptom was relieved or disappeared after treatment. Conclusion Asthenopia can be diagnosed on the base of corneal epithelium post fibrosis. Chondroitin Sulfate Eye Drops are effective in the treatment of asthenopia.

关 键 词：视疲劳 诊断 药物治疗 

分 类 号：R772.2[医药卫生—眼科]